Hardware Podcasts

Protecting the Intellectual Property of your Medical Device Technology

Global Medical Device Podcast · 22 Jul 2020 · 39m · Episode 156

What this episode covers

Kevin Buckley and Neil Thompson from Torrey Pines Law Group discuss intellectual property strategies for software as a medical device (SaMD) and AI-enabled technologies. They explain the Alice two-step rule for patent eligibility, the trade-offs between patents and trade secrets, and the importance of competitive intelligence and patent searches. The guests also address how IP strategy intersects with FDA regulatory pathways like 510(k) and De Novo.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Torrey Pines Law Group, Green Light Guru
Also
FDA, Alice

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 03m

    021 - "Options" with Karandeep Singh Badwal

    Karandeep Singh Badwal, a QA/RA consultant and host of The MedTech Podcast, explains how defining 'intended use' determines whether a product is a regulated medical device or unregulated software, a critical distinction for startups. He details the specific regulatory challenges of Software as a Medical Device (SaMD), including cybersecurity, GDPR compliance, and the impact of the EU MDR on software classification. Badwal also discusses the strategic advantages for UK software companies post-Brexit, where they can still self-certify as Class 1 devices while EU counterparts face stricter notified body audits.

    Validation & product-market fitQuality & yield
    9 chapters

  • Let's Combinate · 34m

    172 - Regulatory AI Innovations, Drugs@FDA Database, Regulatory Intelligence Strategies, Human Factors Insights, and Smarter Submission Approaches with Doug Mead

    Doug Mead, founder of CP Pathways and Rhizome AI, explains how his company uses AI to search the FDA's Drugs@FDA database, enabling faster regulatory intelligence for combination products. He details the transition from manual Google searches to a specialized tool that handles OCR and semantic search to interpret review memos, human factors data, and Type C meeting minutes. Mead highlights the value of understanding FDA precedents for products like auto-injectors and on-body injectors, while noting limitations such as redacted data and unpublished supplement reviews.

    Connected products & IoTCertification & compliance
    7 chapters

  • The Pragmatic Embedded Podcast · 37m

    Rapid Prototyping for Medical Devices with Ross Dehmoobed

    Ross Dehmoobed, VP of software and platforms at Veranex, explains how his company applies agile methodologies to medical device development. He details the use of 'Fusion Core' libraries and custom hardware modules to enable rapid prototyping, allowing teams to demonstrate functional breadboards and software features within the first two weeks. Dehmoobed emphasizes that while planning and regulatory pathway definition (such as 510(k) or de novo) require upfront waterfall-style rigor, the execution phase benefits from short sprints, off-target unit testing, and continuous customer feedback to maintain quality and speed.

    Prototyping & iterationEmbedded firmware
    7 chapters

  • Let's Combinate · 31m

    206 - Will AI Decide Your Next Drug/Device Approval?

    Dominick Romano, founder of Drainpipe.io, explains how AI can be regulated in pharma and medtech by applying ICH guidelines and process validation to AI systems. He argues that pharmaceuticals are uniquely suited for AI because both deal with 'combinatorial problem sets' involving infinite inputs and outputs, requiring rigorous validation to prevent hallucinations in regulatory dossiers. Romano details how AI can accelerate dossier preparation by reducing millions of working hours in data acquisition and how regulators might use AI agents to speed up review processes, provided the technology is proven safe and accurate by the companies themselves.

    AI & machine learningCertification & compliance
    8 chapters

  • Let's Combinate · 36m

    094 - Connected Combination Products, Product Traceability, Regulating New Products, Pre-Determined Changes and AI/ML with Rumi Young

    Rumi Young, Director of Regulatory Policy at Becton Dickinson (BD), discusses the regulatory challenges of smart connected combination products, such as insulin pens and on-body injectors, which integrate sensors, apps, and AI/ML. She explains how unit-level traceability using RFID can optimize manufacturing and clinical trials, while highlighting the current regulatory silos at the FDA that hinder consistent policy for these cross-therapeutic technologies. Young advocates for a single source of truth within the FDA to streamline the use of tools like comparability protocols and predetermined change control for post-market algorithm updates.

    Connected products & IoTAI & machine learning
    8 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.